Abstract
The classical method for treating osteogenic sarcoma had been amputation followed by chemotherapy for about 1 year. Recently, preoperative chemotherapy has been tried in many cancer centers [1–3], with the resultant benefits of controlling micrometastasis, permitting the analysis of the response of the tumor to chemotherapy, and providing a better chance to save the endangered limb by reducing and consolidating the tumor volume [4]. Intra-arterial preoperative chemotherapy has been shown to control local lesions very effectively [3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eilber F, Grant T, Morton D (1978) Adjuvant therapy for osteosarcoma: Preoperative and postoperative treatment. Cancer Treat Rep 62: 213–216
Rosen G, Caparros B, Huvos A, Kosloff C, Nirrenberg A, Cacavio A, Marcove R, Lane J, Metha B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma. (Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy). Cancer 49: 1221–1230
Stine KC, Hockenberry MJ, Harrelson I, Miner D, Falletta JM (1989) Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. Cancer 63: 848–853
Simon MA, Aschliman M, Thomas N, Mankin HJ (1986) Limb salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone and Joint Surg [Am] 68: 1331–1337
Ochs J, Freeman A, Douglass HJ, Hingby D, Mindell E, Sinks L (1978) Cisdiamminedichloroplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62: 239–245
Jaffe N, Knapp J, Chuang V, Wallace C, Ayala A, Murray J, Cangir A, Wang A, Benzamin R (1983) Osteosarcoma: Intraarterial treatment of the primary tumor with cis-Diamminedichloroplatinum II (CDP): Angiographic, pathologic and pharmacologic studies. Cancer 51: 402–407
Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop 204: 9–24
Huvos AG, Rosen G, Marcove CR (1977) Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101 (1): 14–18
Kaplan EL, Meier R (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457–481
Benjamin R, Chawla S, Carrasco C (1988) Arterial infusion in the treatment of osteosarcoma. In: Ryan J, Baker L (eds) recent concepts in sarcoma treatment. Kluwer, Dordrecht, pp 269–274
Jaffe N (1989) Chemotherapy for malignant bone tumors. Orthop Clin North America 20 (3): 487–503
Jaffe N, Prudich J, Knapp J, Wang Y, Bowman R, Cangir A, Ayala A, Chuang V, Wallace S (1983) Treatment of primary osteosarcoma with intraarterial and intravenous high dose methotrexate. J Clin Oncol 1 (7): 428–431
Jaffe N, Raymond A, Ayala A, Carrasco C, Wallace S, Robertson R, Griffiths M, Wang Y (1989) Effect of cumulative courses of intraarterial cisDiamminedichloroplatinum-II on the primary tumor in pediatric osteosarcoma. Cancer 63: 63–67
Jaffe N, Spears R, Eftekhari F, Robertson R, Cangir A, Takaue Y, Carrasco C (1987) Pathologic fracture in osteosarcoma: Impact of chemotherapy on primary tumor and survival. Cancer 59: 27–35
Carter SK (1980) The dilemma of adjuvant chemotherapy for osteogenic sarcoma. Cancer Clin Trials 3: 29–36
Dahlin DC, Coventry MB (1967) Osteosarcoma: A study of 600 cases. J Bone Joint Surg [Am] 49: 101–110
Friedman MA, Carter SX (1972) The therapy of osteogenic sarcoma: Current status and thoughts for the future. J surg Oncol 4 (5): 482–510
Taylor WF, Ivins JC, Dahlin DC, Edmonson JH, Pritchard DJ (1978) Trends and variability in survival from osteosarcoma. Mayo Clin Proc 53: 695–700
Weiner M, Harris M, Lewis M, Jones R, Sherry H, Feurer E, Johnson T, Lahman E (1986) Neoadjuvant high dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma. Cancer Treat Rep 70: 1431–1432
Baum E, Greenberg L, Gaynon P (1978) Use of cisplatinumdiammine dichloride (CPDD) in osteogenic sarcoma (OS) in children (abstract C-315). Proc AACRASCO 19: 335
Nitschke R, Starling KA, Vats T, Bryan H (1978) Cis-Diamminedichloroplatinum (NSC-119875) in childhood malignancies: A southwest oncology group study. Med Pediatr Oncol 4: 127–132
Pratt C, Hayes F, Green A (1979) Phase II pharmacokinetic study of cis-platinum diamminedichloride (CPDD) in children with solid tumors. Proc AACR-ASCO 20: 361
Baram TZ, van Tassel P, Jaffe NA (1988) Brain metastasis in osteosarcoma: Incidence, clinical and neurological findings and management options. J Neurooncol 6: 47–52
Giuliano A, Feig S, Eilber F (1984) Changing metastatic patterns of osteosarcoma. Cancer 54: 2160–2164
McCarten KM, Jaffe N, Kirkpatrick JA (1980) The changing radiographic appearance of osteogenic sarcoma. Ann Radiol 23: 203–208
Takaue Y, Slopis JM, Anzai T, Robertson R, Jaffe N (1985) Successful treatment of pulmonary and abdominal metastatic osteosarcoma. Med Pediatr Oncol 13: 126128
Eckardt II, Eilber FR, Dorey FI, Mirra IM (1987) The UCLA experience in the management of stage IIB osteosarcoma: 1972–1983. In: Enneking WF (ed) Limb salvage in musculoskeletal oncology. Churchill Livingstone, New York, pp 314–326
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Japan
About this paper
Cite this paper
Lee, SY., Chung, C.Y., Baek, G.H., Byun, H.S. (1992). Intra-Arterial Cisplatin Chemotherapy for Osteogenic Sarcoma. In: Uchida, A., Ono, K. (eds) Recent Advances in Musculoskeletal Oncology. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68364-3_10
Download citation
DOI: https://doi.org/10.1007/978-4-431-68364-3_10
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68366-7
Online ISBN: 978-4-431-68364-3
eBook Packages: Springer Book Archive